Brevan Howard Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-16,965	Closed	-$465K	–	1259
2024 Q3	$465K	Buy	16,965 +2,349	+16%	+$64.3K	﹤0.01%	646
2024 Q2	$358K	Buy	+14,616	New	+$358K	﹤0.01%	669